A crude significant predictor in the liver was IGFBP-6 (SS and NASH), whereas IGFBP-3 adjusted by lipids was a predictor for NASH (Supplementary Table S1). This evidence concerns the gene IGFBP3 and metabolic dysfunction-associated steatohepatitis.